CCR5 and neoplasm: Experiments have shown an increased frequency of CCR5‐expressing MDSCs in melanoma lesions compared with their frequency in the bone marrow and peripheral blood; furthermore, the expression levels of CCR5 on MDSCs also increase during tumor progression [185].